FDA Brief

Warning letters Drugs

FDA warning letter to

www.usaquickmeds.com

High riskIssued Aug 1, 2025Posted Aug 19, 2025Center for Drug Evaluation and Research (CDER)

FDA warned usaquickmeds.com for selling unapproved and misbranded opioids and benzodiazepines online without prescriptions.

What happened

FDA reviewed the website www.usaquickmeds.com and found it offered tapentadol, tramadol, alprazolam, and lorazepam for sale to U.S. consumers. FDA said the site sold these prescription drugs without a prescription and without FDA-approved applications, making them unapproved and misbranded. The letter cites website claims that the products treat pain, anxiety, and other conditions.

What FDA found

  1. The website sold tapentadol, tramadol, alprazolam, and lorazepam as new drugs without FDA-approved applications.

    FD&C Act §§ 301(d), 505(a) [21 U.S.C. §§ 331(d), 355(a)]
  2. The prescription drugs' labeling did not include adequate directions for use by a layperson.

    FD&C Act § 502(f)(1) [21 U.S.C. § 352(f)(1)]; 21 CFR 201.5
  3. The website offered prescription drugs for sale without requiring a prescription.

    FD&C Act §§ 503(b)(1), 301(k) [21 U.S.C. §§ 353(b)(1), 331(k)]
  4. The website caused misbranded drugs to be introduced into interstate commerce by offering them for sale to U.S. consumers.

    FD&C Act § 301(a) [21 U.S.C. § 331(a)]

What FDA wants

FDA asks the company to stop offering any unapproved and misbranded drugs to U.S. consumers. It must reply in writing within 15 working days describing corrective steps and how it will prevent recurrence.

Who should pay attention

  • online pharmacies selling to U.S. consumers
  • companies that fulfill or distribute prescription drugs
  • regulatory teams monitoring internet drug promotion

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk
  4. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk